CGN NEW ENERGY (01811) repurchased 566,000 shares at a cost of HKD 1.2122 million on September 8.
China General Nuclear Power New Energy (01811) announced that on September 8, 2026, the company spent HKD 1.2122 million to repurchase 566,000 shares.
CGN NEW ENERGY (01811) announced that on September 8, 2026, the company spent HK$1.2122 million to repurchase 566,000 shares.
Related Articles
Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.
CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.
Shanghai Fosun Pharmaceutical (02196) subsidiary has received approval for clinical trials of its medication.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.
CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.
Shanghai Fosun Pharmaceutical (02196) subsidiary has received approval for clinical trials of its medication.
RECOMMEND
